Rosen Law Firm Initiates Class Action for Altimmune Stockholders Over Alleged Misleading Trial Results
Rosen Law Firm, a global investor rights law firm, has announced a class action lawsuit on behalf of shareholders of Altimmune, Inc. (NASDAQ: ALT)....